Health App Recommendation Tool for Alzheimer's Disease

(HART Trial)

Not yet recruiting at 1 trial location
JM
Overseen ByJulie M Faieta, PhD, MOT
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Pittsburgh
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests the Health App Recommendation Tool (HART) to evaluate its effectiveness in helping caregivers of individuals with Alzheimer's or similar diseases find useful apps. HART is not an app itself but matches caregivers with apps that suit their needs and preferences. The trial aims to determine if HART is easy to use and helpful in real-life situations. Suitable participants are active caregivers for someone with Alzheimer's who have access to smart devices like phones or tablets. As an unphased trial, this study offers caregivers the chance to contribute to innovative solutions that could simplify their caregiving journey.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on using a digital tool, so it's unlikely that medication changes are required.

What prior data suggests that the Health App Recommendation Tool (HART) is safe for use by individuals with Alzheimer's disease and related dementias or their caregivers?

Research has shown that the Health App Recommendation Tool (HART) evaluates apps rather than serving as a treatment or medication, eliminating concerns about side effects. HART assists people with Alzheimer's and their caregivers in finding suitable health apps. Users have reported no negative effects from using this tool. Instead, it simplifies and enhances the process of selecting helpful apps. Therefore, users can safely try it without concern for harmful effects.12345

Why are researchers excited about this trial?

Researchers are excited about the Health App Recommendation Tool (HART) because it offers a personalized approach to managing Alzheimer's disease. Unlike standard treatments that often rely on medications or therapy, HART uses an algorithm to match individual needs with tailored health app recommendations. This innovative method empowers participants by giving them control over their care, potentially enhancing quality of life and usability. By providing specific app suggestions, HART could make managing Alzheimer's symptoms more accessible and customized to each person's unique situation.

What evidence suggests that the Health App Recommendation Tool is effective for Alzheimer's disease?

Research has shown that the Health App Recommendation Tool (HART) helps find the best health apps for people with Alzheimer's disease and related dementias (ADRD). In this trial, participants will use HART, which employs a special program to choose apps based on individual needs and preferences. Early results suggest that these personalized app suggestions enhance user satisfaction and engagement. This method aims to improve life quality by linking users with helpful digital tools for health and wellness. While researchers are still gathering specific data on HART's effectiveness, its research-based design appears promising.12456

Who Is on the Research Team?

JM

Julie M Faieta, PhD, MOT

Principal Investigator

University of Pittsburgh

Are You a Good Fit for This Trial?

This trial is for active caregivers aged 18 to 65 who are looking after someone with Alzheimer's or related dementia. They must have access to smart devices like phones, tablets, or watches. It's not for those with dementia themselves, part-time caregivers, or anyone without a smart device.

Inclusion Criteria

Serving as active caregivers for their loved one with Alzheimer's Disease and Related Dementia
Have access to smart devices such as smartphones, smart tablets, smart watches, etc.
I am between 18 and 65 years old.

Exclusion Criteria

Individuals with Alzheimer's Disease or Related Dementia, or with severe cognitive decline, will be excluded
Participants who do not provide caregiving routinely (part-time or secondary caregiver) will be excluded
Participants who do not own or have access to any Smart device will be excluded.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Pre-intervention

Participants complete baseline surveys and a virtual onboarding session to learn about the Health App Recommendation Tool (HART) and create a profile.

1 week
1 virtual visit

Intervention

Participants use the recommended health apps in their home settings, interacting with them as desired.

4 weeks

Follow-up

Participants complete follow-up assessments to evaluate the impact of the intervention on health and quality of life.

1 week
1 virtual visit

What Are the Treatments Tested in This Trial?

Interventions

  • Health App Recommendation Tool (HART)
Trial Overview The study tests the Health App Recommendation Tool (HART), which suggests apps based on the needs and preferences of people with Alzheimer's/dementia and their caregivers. Participants will use HART over a four-week period and provide feedback through surveys.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: HART UseExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+

Citations

Evaluating the Effectiveness of the Health App ...This study aims to assess the effectiveness of the Health App Recommendation Tool (HART), an evidence-based tool that evaluates app features ...
Evaluating the Effectiveness of the Health App ... - MedPathThis study aims to assess the effectiveness of the Health App Recommendation Tool (HART), an evidence-based tool that evaluates app features ...
Evaluating the Effectiveness of the Health App ...This study aims to assess the effectiveness of the Health App Review Tool (HART), an evidence-based tool that evaluates app features, then matches these ...
4.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/38630031/
Health App Review Tool (HART): Content validation ...The Health App Review Tool (HART) is an evaluation tool that is designed to help the users in evaluation of the health apps for Alzheimer's Disease and Related ...
Health App Recommendation Tool for Alzheimer's Disease ...This study aims to assess the effectiveness of the Health App Recommendation Tool (HART), an evidence-based tool that evaluates app features, then matches ...
(PDF) Health App Review Tool: Matching mobile ...The Health App Review Tool (HART) is a novel assessment designed to match users with Alzheimer's disease or related dementias (ADRD) and caregivers to mobile ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security